{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T18:38:55Z","timestamp":1778870335387,"version":"3.51.4"},"reference-count":7,"publisher":"BMJ","issue":"10","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/bmj.com\/coronavirus\/usage"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2021,9,19]]},"published-print":{"date-parts":[[2021,10]]},"abstract":"<jats:p>With increasing presentations of headaches following COVID-19 vaccination, we present one of the UK\u2019s earliest proven cases of vaccine-induced thrombotic thrombocytopaenia (VITT), with the aim of giving colleagues a case to compare other patients against. Our patient was a 48-year-old man who presented with frank haematuria, a widespread petechial rash, and headaches, 2 weeks after receiving the first dose of the Oxford AstraZeneca ChAdOx1 nCoV-19 vaccine. He had a platelet count of 14\u00d710<jats:sup>9<\/jats:sup>\/L and an extensive cerebral venous sinus thrombosis (CVST) with subarachnoid haemorrhage on imaging. He developed localising neurological signs and experienced a cardiopulmonary arrest. He was successfully resuscitated and transferred to a tertiary care centre for urgent thrombectomy. This case illustrates how the diagnosis of VITT should be based on the platelet count and imaging\u2014and how patients with VITT should be cared for in centres with urgent neurosurgical and interventional radiology services.<\/jats:p>","DOI":"10.1136\/bcr-2021-245440","type":"journal-article","created":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T13:11:30Z","timestamp":1633612290000},"page":"e245440","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":15,"title":["Haematuria, a widespread petechial rash, and headaches following the Oxford AstraZeneca ChAdOx1 nCoV-19 Vaccination"],"prefix":"10.1136","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6976-5808","authenticated-orcid":false,"given":"Ammar","family":"Waraich","sequence":"first","affiliation":[{"name":"Department of Acute Medicine, Worcestershire Acute Hospitals NHS Trust, Worcester, Worcestershire, England, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Williams","sequence":"additional","affiliation":[{"name":"Department of Acute Medicine, Worcestershire Acute Hospitals NHS Trust, Worcester, Worcestershire, England, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2021,10,7]]},"reference":[{"key":"2025082623540660000_14.10.e245440.1","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1056\/NEJMe2106315","article-title":"SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia","volume":"384","author":"Cines","year":"2021","journal-title":"N Engl J Med"},{"key":"2025082623540660000_14.10.e245440.2","doi-asserted-by":"crossref","unstructured":"Schultz N , S\u00f8rvoll I , Michelsen A . Thrombosis and thrombocytopaenia after ChAdOx1 nCoV-19 vaccination. N Engl J Med 2021.doi:10.1056\/NEJMoa2104882","DOI":"10.1056\/NEJMoa2104882"},{"key":"2025082623540660000_14.10.e245440.3","unstructured":"Medicines and Healthcare products Regulatory Agency . Coronavirus vaccine - weekly summary of Yellow Card reporting, 2021. Available: https:\/\/www.gov.uk\/government\/publications\/coronavi rus-covid-19-vaccine-adverse-reactions\/coronavirus-vaccine-summary-of-yellow-card-reporting [Accessed 25 Jun 2021]."},{"key":"2025082623540660000_14.10.e245440.4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2104840"},{"key":"2025082623540660000_14.10.e245440.5","unstructured":"Royal College of emergency medicine, Society for acute medicine, Royal College of physicians. management of patients presenting to the emergency Department\/ acute medicine with symptoms. Royal College of emergency medicine, Society for acute medicine, Royal College of physicians, 2021. Available: https:\/\/www.rcem.ac.uk\/docs\/Policy\/ED-AM%20%20Vaccine%20pathway%20concerns%20-%20RCP%20-%20SAM%20-%20RCEM.pdf"},{"key":"2025082623540660000_14.10.e245440.6","unstructured":"Pavord S , Lester W , Makris M . Guidance from the expert haematology panel on Covid-19 vaccine-induced immune Thrombocytopaenia and thrombosis. United Kingdom expert haematology panel, 2021. Available: https:\/\/b-s-h.org.uk\/media\/19590\/guidance-version-17-on-mngmt-of-vitt-20210420.pdf"},{"key":"2025082623540660000_14.10.e245440.7","unstructured":"Public Health England . Blood clotting following COVID-19 vaccination: information for health professionals. public health England, 2021. Available: assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/992072\/PHE_COVID-19_AZ_vaccine_and_blood_clots_factsheet_8June21.pdf"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2021-245440","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T06:54:16Z","timestamp":1756277656000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2021-245440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":7,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,10,7]]},"published-print":{"date-parts":[[2021,10]]}},"alternative-id":["10.1136\/bcr-2021-245440"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2021-245440","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10]]}}}